Advancing Hair Loss Solutions As August marks Hair Loss Awareness Month, the Journal of Drugs in Dermatology (JDD) continues to champion evidence-based approaches for practicing dermatologists navigating this challenging field.…
Read More
Guest: Dr. Adelina Hung For decades, corticosteroids have been the gastrointestinal equivalent of duct tape: they fix almost everything, at least long enough to convince us the job is done.…
Read More
GLP-1 Receptor Agonists and Psoriasis: The Next Frontier in Metabolic Dermatology? A groundbreaking study published in the Journal of Drugs in Dermatology highlights a compelling link between metabolic therapy and…
Read More
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Nada Elbuluk, MD, MSc, FAAD, one of the co-authors of Public Interest in Hyperpigmentation: Insights From a Google Trends…
Read More
Your ultimate, comprehensive hub for everything related to pigmentary disorders. Whether you are looking to deepen your clinical knowledge, catch up on the latest dermatological breakthroughs, or optimize your patient…
Read More
Targeted Topical Approaches in Acanthosis Nigricans: Evaluating Sirolimus Gel 0.2% This is a must-read article from the JDD for clinicians treating complex pigmentary and metabolic dermatoses. Acanthosis nigricans remains a…
Read More
Exploring the Potential of Moringa Formulations in Hair Health and Alopecia Management Have you read this compelling new systematic review from the Journal of Drugs in Dermatology. As hair loss,…
Read More
Skin of Color: Bridging the Knowledge Gap As the patient population becomes more diverse in the United States, it is becoming increasingly important for dermatologists to be comfortable counseling patients…
Read More
Join Janiene Luke, MD, to discover how MELAB3’s breakthrough active, Melasyl (2 MNG), intercepts melanin precursors before they form dark spots, setting a new standard for safety and efficacy across…
Read More
Hair loss is a widespread condition with a potentially severe psychological burden, especially among women. The chance of suffering from female alopecia increases with menopause, and topical treatments beyond minoxidil…
Read More
MedPage Today/Dermatology World Weekly highlighted a Journal of Drugs in Dermatology study comparing a topical JAK inhibitor with a common topical steroid in atopic dermatitis (AD). The study, “Ruxolitinib Cream…
Read More
New JDD Data Explore PLLA-SCA for Posterior Thigh Cellulite Have you read this article from the JDD? A new 12 month study is drawing attention for practicing dermatologists and dermatology…
Read More
